Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial.
OpenAlex 토픽 ·
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Cancer survivorship and care
[OBJECTIVE] This study aims to determine the impact of PROM with a personalized follow-up program on the evaluation of quality of life and self-management for patients after lung cancer resection.
APA
Yiqing Luo, Y. Cheng, et al. (2026). Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial.. Asia-Pacific journal of oncology nursing, 13, 100844. https://doi.org/10.1016/j.apjon.2025.100844
MLA
Yiqing Luo, et al.. "Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial.." Asia-Pacific journal of oncology nursing, vol. 13, 2026, pp. 100844.
PMID
41625083
Abstract
[OBJECTIVE] This study aims to determine the impact of PROM with a personalized follow-up program on the evaluation of quality of life and self-management for patients after lung cancer resection.
[METHODS] Given a formal power calculation a total of 240 patients with lung cancer. Participants were randomly assigned to either the experimental or the control groups. Patients in the experimental group received a personalized follow-up program of patient-reported outcomes. The control group received only the telephone follow-up. Baseline data (T0) were collected before the intervention (on the day of discharge), and quality of life, self-efficacy, and compliance were measured at 2 weeks (T1), 4 weeks (T2), and 4 months (T3) post-discharge.
[RESULTS] The difference in quality of life between the experimental and control groups was significant (Wald χ = 5.204, = 0.023), with the experimental group showing significantly better quality of life at T2 compared to the control group ( = 2.515, = 0.013). Both groups showed improvements in quality of life at all post-test time points (Wald χ = 574.167, < 0.001), and the interaction between group and time was not statistically significant (Wald χ = 2.354, = 0.308). Regarding self-management efficacy, Generalized Estimating Equations results indicated a significant difference between the experimental and control groups (Wald χ = 6.573, = 0.010), with the experimental group showing significantly higher self-management efficacy at T2 and T3 compared to the control group ( = 3.024, = 0.003; = 2.214, = 0.028). No significant differences were observed at T0 and T1. Both groups showed improvements in self-management efficacy at all post-test time points (Wald χ = 301.390, < 0.001), and the interaction between group and time was not statistically significant (Wald χ = 3.971, = 0.137).
[CONCLUSIONS] For patients after lung cancer surgery, the program has optimized the evaluation of postoperative quality of life and self-management efficacy.
[TRIAL REGISTRATION] Chinese Clinical Trial Registry (NCT06483295).
[METHODS] Given a formal power calculation a total of 240 patients with lung cancer. Participants were randomly assigned to either the experimental or the control groups. Patients in the experimental group received a personalized follow-up program of patient-reported outcomes. The control group received only the telephone follow-up. Baseline data (T0) were collected before the intervention (on the day of discharge), and quality of life, self-efficacy, and compliance were measured at 2 weeks (T1), 4 weeks (T2), and 4 months (T3) post-discharge.
[RESULTS] The difference in quality of life between the experimental and control groups was significant (Wald χ = 5.204, = 0.023), with the experimental group showing significantly better quality of life at T2 compared to the control group ( = 2.515, = 0.013). Both groups showed improvements in quality of life at all post-test time points (Wald χ = 574.167, < 0.001), and the interaction between group and time was not statistically significant (Wald χ = 2.354, = 0.308). Regarding self-management efficacy, Generalized Estimating Equations results indicated a significant difference between the experimental and control groups (Wald χ = 6.573, = 0.010), with the experimental group showing significantly higher self-management efficacy at T2 and T3 compared to the control group ( = 3.024, = 0.003; = 2.214, = 0.028). No significant differences were observed at T0 and T1. Both groups showed improvements in self-management efficacy at all post-test time points (Wald χ = 301.390, < 0.001), and the interaction between group and time was not statistically significant (Wald χ = 3.971, = 0.137).
[CONCLUSIONS] For patients after lung cancer surgery, the program has optimized the evaluation of postoperative quality of life and self-management efficacy.
[TRIAL REGISTRATION] Chinese Clinical Trial Registry (NCT06483295).
같은 제1저자의 인용 많은 논문 (5)
- Clinical Application of PARP1 Inhibitors and Challenges in Cancer Therapy.
- Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy-Induced Cardiac Fibrosis Based on Single-Cell Transcriptomic Analysis.
- Commentary: Acceptance and commitment therapy combined with usual care improves psychosocial outcomes and reduces complications in patients with permanent colostomies after colorectal cancer surgery: a retrospective cohort study.
- A novel triple-modality approach overcoming prohibitive hepatopulmonary shunt (HPS): Enabling yttrium-90 selective internal radiation therapy (Y90-SIRT) and subsequent curative resection in massive hepatocellular carcinoma (HCC).
- Symptom Clusters and Influencing Factors in Adult Patients With Haematological Malignancies During Chemotherapy: A Cross-Sectional Study.